34:. The field encompasses issues related to both diagnosis and management of these conditions, including rehabilitation interventions to optimize the quality of life of individuals with these conditions. This field encompasses disorders that impact both adults and children and which can be inherited or acquired, typically from an
46: Many recent drug therapies have been developed to address the acquired neuromuscular diseases including but not limited to immune suppression and drugs that increase the
54:. Gene modifying therapies are also a recent treatment branch of neuromuscular medicine with advancements made in disorders such as
103:"The role of the neuromuscular medicine and physiatry specialists in the multidisciplinary management of neuromuscular disease"
27:
193:
Thornton CA, Griggs RC (March 1994). "Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease".
236:
Gilhus NE, Verschuuren JJ (October 2015). "Myasthenia gravis: subgroup classification and therapeutic strategies".
71:
59:
38:. A neurologist or physiatrist can diagnose these diseases through a clinical history, examination, and
279:
Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, Goodspeed K, Gray SJ, Kay CN, et al. (February 2021).
334:
55:
51:
43:
81:
31:
8:
339:
305:
280:
261:
218:
175:
127:
102:
35:
249:
310:
253:
210:
167:
132:
265:
222:
179:
300:
292:
245:
202:
159:
122:
114:
47:
39:
296:
118:
328:
314:
257:
171:
163:
136:
214:
206:
278:
23:
281:"Current Clinical Applications of In Vivo Gene Therapy with AAVs"
76:
107:
Physical
Medicine and Rehabilitation Clinics of North America
16:
Specialty of medicine that focuses on neuromuscular diseases
150:
Morrison BM (October 2016). "Neuromuscular
Diseases".
235:
326:
192:
100:
30:that focuses the diagnosis and management of
94:
304:
126:
149:
327:
101:McDonald CM, Fowler WM (August 2012).
13:
14:
351:
72:List of neuromuscular disorders
272:
229:
186:
143:
1:
250:10.1016/S1474-4422(15)00145-3
87:
7:
297:10.1016/j.ymthe.2020.12.007
65:
60:Duchenne muscular dystrophy
10:
356:
119:10.1016/j.pmr.2012.06.010
44:nerve conduction studies.
56:spinal muscular atrophy
164:10.1055/s-0036-1586263
52:neuromuscular junction
32:neuromuscular diseases
20:Neuromuscular medicine
238:The Lancet. Neurology
207:10.1002/ana.410350304
152:Seminars in Neurology
82:Motor neuron diseases
22:is a subspecialty of
195:Annals of Neurology
36:autoimmune disease
285:Molecular Therapy
244:(10): 1023–1036.
48:neurotransmitters
347:
319:
318:
308:
276:
270:
269:
233:
227:
226:
190:
184:
183:
147:
141:
140:
130:
98:
40:electromyography
355:
354:
350:
349:
348:
346:
345:
344:
335:Neurophysiology
325:
324:
323:
322:
277:
273:
234:
230:
191:
187:
148:
144:
99:
95:
90:
68:
17:
12:
11:
5:
353:
343:
342:
337:
321:
320:
291:(2): 464–488.
271:
228:
201:(3): 260–268.
185:
158:(5): 409–418.
142:
113:(3): 475–493.
92:
91:
89:
86:
85:
84:
79:
74:
67:
64:
15:
9:
6:
4:
3:
2:
352:
341:
338:
336:
333:
332:
330:
316:
312:
307:
302:
298:
294:
290:
286:
282:
275:
267:
263:
259:
255:
251:
247:
243:
239:
232:
224:
220:
216:
212:
208:
204:
200:
196:
189:
181:
177:
173:
169:
165:
161:
157:
153:
146:
138:
134:
129:
124:
120:
116:
112:
108:
104:
97:
93:
83:
80:
78:
75:
73:
70:
69:
63:
61:
57:
53:
49:
45:
41:
37:
33:
29:
25:
21:
288:
284:
274:
241:
237:
231:
198:
194:
188:
155:
151:
145:
110:
106:
96:
19:
18:
329:Categories
88:References
62:.
42:including
340:Neurology
28:physiatry
24:neurology
315:33309881
266:19615369
258:26376969
223:42256684
180:13937705
172:27704495
137:22938874
66:See also
306:7854298
215:8122878
128:3482408
50:at the
313:
303:
264:
256:
221:
213:
178:
170:
135:
125:
77:Muscle
262:S2CID
219:S2CID
176:S2CID
311:PMID
254:PMID
211:PMID
168:PMID
133:PMID
58:and
26:and
301:PMC
293:doi
246:doi
203:doi
160:doi
123:PMC
115:doi
331::
309:.
299:.
289:29
287:.
283:.
260:.
252:.
242:14
240:.
217:.
209:.
199:35
197:.
174:.
166:.
156:36
154:.
131:.
121:.
111:23
109:.
105:.
317:.
295::
268:.
248::
225:.
205::
182:.
162::
139:.
117::
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.